Oral Mucosal Immunity and Microbiome

CHF 279.95
Auf Lager
SKU
D23LFCVR89L
Stock 1 Verfügbar
Geliefert zwischen Fr., 21.11.2025 und Mo., 24.11.2025

Details

The first International Conference on Oral Mucosal Immunity and Microbiome (OMIM) aimed to highlight cutting-edge basic and translational research from an oral immunological and microbiological perspective. Oral diseases with a microbial etiology are the most prevalent chronic diseases of humans. Whilst not life-threatening, they can significantly compromise quality of life, are associated with increased risk for certain systemic diseases, and pose heavy financial burdens to national health systems. Hence, periodontal and peri-implant diseases, dental caries, root canal infections and mucosal infections are significant global public health problems.
In this book global experts summarize and discuss the latest progress made in oral mucosal immunity and the oral microbiome. Target audience is basic and/or translational researchers with expertise in host immunity and microbiome research, and interest in oral health and disease. This volume provides a much needed quantum leap in the field, by joining forces to address gaps at the oral mucosal immunity-microbiome cross-talk.

Highlights selections from the 1st International Conference on Oral Mucosal Immunity and Microbiome (OMIM), held in September 2018 Focuses on multi-omic technologies that are progressing the field of the oral microbiome Ideal reference for basic or translational researchers

Autorentext

Georgios N. BelibasakisKarolinska Institute Department of Dental MedicineDepartment of Dental MedicineHuddingeStockholms LänSweden
Nagihan BostanciKarolinska Institute Department of Dental MedicineHuddingeStockholms LänSweden
Michael A. CurtisKing's College London Dental InstituteLondonUnited Kingdom
George HajishengallisUniv of Pennsylvania Penn Dental Med MicrobioPenn Dental Med MicrobioPhiladelphiaPennsylvaniaUSA







Inhalt

  1. Advances in oral mucosal immunity and the microbiome.- 2. Trained innate immunity and its implications for mucosal immunity and inflammation.- 3. Signaling systems in oral bacteria.- 4. Origin of Th17 cells in Type 2 Diabetes-Potentiated Periodontal Disease.- 5. Gingival epithelial cell recognition of lipopolysaccharide.- 6. The relationship of Candida albicans with the oral bacterial microbiome in health and disease.- 7. A potential role of Phospholipase 2 group IIA (PLA2-IIA) in P. gingivalis-induced oral dysbiosis.- 8. Helicobacter spp. in experimental models of colitis.- 9. T Helper 17 cells as pathogenic drivers of periodontitis.- 10. Candida-bacterial biofilms and host-microbe interactions in oral diseases.- 11. Comparative analysis of gene expression patterns for oral epithelium-related functions with aging.- 12. Neutrophil interaction with emerging oral pathogens: a novel view of the disease paradigm.- 13. Biologically-defined or biologically-informed traits are more heritable than clinically-defined ones: the case of oral and dental phenotypes.-

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Editor Georgios N. Belibasakis, George Hajishengallis, Nagihan Bostanci, Michael A. Curtis
    • Titel Oral Mucosal Immunity and Microbiome
    • Veröffentlichung 16.11.2020
    • ISBN 303028526X
    • Format Kartonierter Einband
    • EAN 9783030285265
    • Jahr 2020
    • Größe H254mm x B178mm x T12mm
    • Untertitel Advances in Experimental Medicine and Biology 1197
    • Gewicht 395g
    • Genre Medizin
    • Lesemotiv Verstehen
    • Anzahl Seiten 204
    • Herausgeber Springer
    • GTIN 09783030285265

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470